Current Issues With the Use of Bedaquiline

Chahine EB Karaoui LR Mansour H . Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis [published online November 1, 2013]. Ann Pharmacother. doi:10.1177/1060028013504087.

World Health Organization. The Use of Bedaquiline in the Treatment of Multidrug-Resistant Tuberculosis: Interim Policy Guidance. Geneva, Switzerland: World Health Organization; 2013. http://apps.who.int/iris/bitstream/10665/84879/1/9789241505482_eng.pdf. Accessed January 11, 2013.

Marshall H . New drug approved for MDR tuberculosis, despite concerns. Lancet. 2013. http://download.thelancet.com/flatcontentassets/lanres/edch/140113_2_1.pdf. Accessed January 11, 2013.

Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis. MMWR Recomm Rep. 2013;62(RR-09):1-12.